ROIV Congressional Stock Trades & Insider Buying (2026)

Regulatory summary: ROIV executive buying and selling activity

Official disclosures filed with the SEC reveal that insiders at Roivant Sciences Ltd. (ROIV) engaged in 28 open-market trades during the past year ending 2026-03-26. Every recorded transaction represented an open-market disposition, yielding 28 sales totaling $627.50M. Shares of Roivant Sciences Ltd. last closed at $35.53, trading within a 52-week band of $16.03 to $41.81 across 249 tracked sessions at 75.6% of the distance between its 52-week low and high. Statutory reporting standards established by federal securities legislation require corporate insiders to disclose transaction telemetry rapidly, providing public market participants with timely visibility into executive portfolio shifts. Institutional market participants evaluate corporate governance disclosures alongside primary market fundamentals to gauge leadership alignment.

ROIV insider buying and selling over the past year

Insiders at Roivant Sciences Ltd. only sold stock in the open market over the past year: 28 Form 4 sales totaling $627.50M, against no open-market purchases.

Only 9 of the 28 sales were flagged as Rule 10b5-1 plan trades, so most selling was discretionary rather than pre-scheduled. Activity clustered in 2025-12 (10 trades) and 2026-02 (6 trades); the latest filing in this window is dated 2026-03-26. Breakdown analytics differentiate 19 non-routine opportunistic trades from 9 scheduled administrative transactions. Cumulative open-market transactions involved 27,492,483 shares, representing 3.8% of the 722,323,015 total shares outstanding. The single largest trade was a sale of 3,000,000 shares worth $82.04M on 2026-02-23.

ROIV insider cost basis and market valuation scenarios

The average open-market sale price was $22.82; the last close of $35.53 is 55.7% above that level, so sellers left upside on the table. Since the most recent regulatory filing the stock has moved +29.9%, from $27.35. Cross-referencing corporate trade executions with secondary market pricing illuminates executive capital timing relative to public equity valuation multiples. Secondary market trading in Roivant Sciences Ltd. equity provides continuous liquidity for corporate insiders and institutional holders alike, balancing executive diversification transactions against broader institutional demand.

Where ROIV trades relative to its one-year range

Roivant Sciences Ltd. closed at $35.53 on 2026-10-06, inside a one-year range of $16.03 to $41.81 across 249 recorded sessions. That puts the stock in the middle of its range, at 75.6% of the distance from low to high. Over one year the share price moved +118.5%, and over roughly three months -2.1%. Average daily volume over the last month was about 8,689,176 shares.

Across 138 companies in the same SEC industry group (SIC 28) with a full year of prices in Gemral Edge, the median one-year return was +7.6%. ROIV is ahead of that median and beat 97% of that peer group on this measure.

Members of Congress who traded ROIV

STOCK Act disclosures show 2 trades in ROIV by 1 members of Congress over five years (0 purchases, 2 sales), most recently on 2025-10-31. The most active traders were Lisa C. McClain (R-MI), 2 trades.

By party the trades split 2 by Republicans; by chamber, 2 from the House.

Roivant Sciences Ltd. federal procurement profile

Official federal contract registries show zero prime procurement obligations awarded to Roivant Sciences Ltd. over monitored fiscal cycles, indicating that commercial customer demand forms the primary revenue engine for the business.

Compare ROIV with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to ROIV:

• MRK one-year return +59.8%
• AMGN one-year return +39.8%
• LLY one-year return +37.0%
• JNJ one-year return +35.4%
• REGN one-year return +26.2%

Sources and method

Metrics reported in this profile reflect deterministic calculations from official filings indexed in Gemral Edge. The analytical methodology evaluates exclusively open-market Form 4 purchases and dispositions, excluding equity awards and gift transfers.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-03-26
• edge_prices_eod (end-of-day close) — as of 2026-10-06
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2025-10-31

ROIV data questions

Are ROIV insiders buying or selling stock?

Insiders at Roivant Sciences Ltd. only sold stock in the open market over the past year: 28 Form 4 sales totaling $627.50M, against no open-market purchases.

What is the one-year price range for ROIV?

Based on end-of-day closes through 2026-10-06, ROIV traded between $16.03 and $41.81, last closing at $35.53.

Has any member of Congress traded ROIV stock?

Yes. 1 members disclosed 2 trades in ROIV over five years; the most recent disclosed trade date is 2025-10-31.